Back

LncRNA PVT1 in brain injury induced by deep hypothermia and low flow.

Yang, Y.; ma, s.; zang, x.; Mo, x.

2024-08-20 cardiovascular medicine
10.1101/2024.08.13.24311905 medRxiv
Show abstract

AimsTo analyze the role of lncRNA PVT1 in cerebral ischemia-reperfusion (I/R) injury induced by deep hypothermia low flow (DHLF). Methods and resultsA total of 72 lncRNAs were differentially expressed in the brain tissue of DHLF mice. PVT1 expression was significantly downregulated in DHLF mouse brain tissue, preoperative and postoperative blood samples from children undergoing DHLF extracorporeal circulation, and hOGD-treated cells. In the mouse model, the DHLF group with PVT1 overexpression had heavier brain tissue damage than the control group; apoptosis rate, reactive oxygen species level and caspase-3 enzyme activity were significantly higher in the lenti-PVT1 group than in the lenti-control group. Compared those in the lenti-control group, the total distance traveled, distance of action in the center, number of entering the center, average speed of walking reduced, and the distance of walking in the periphery and and peripheral walking distance increased in the lenti-PVT1 group. The dual luciferase reporter gene assay verified the possible binding sites between PVT1, miR-148a-3p and MKL1. In the animal model, cellular model, and blood samples of children experiencing DHLF, miR-148a-3p expression increased and MKL1 expression decreased. In experimental studies in vivo and in vitro, PVT1 and MKL1 expression increased, and miR-148a-3p expression decreased. Meanwhile MKL1 inhibitor CCG1423 reversed the apoptosis in neuronal cells. ConclusionPVT1 may adsorb miR-148a-3p to regulate the expression of MKL1, a downstream gene of miR-148a-3p, a mechanism promoting the apoptosis of neuronal cells in DHLF mice.

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Biomedicines
67 papers in training set
Top 0.1%
12.2%
2
PLOS ONE
5266 papers in training set
Top 18%
10.0%
3
Science Bulletin
21 papers in training set
Top 0.1%
8.1%
4
eLife
5828 papers in training set
Top 18%
6.4%
5
European Journal of Pharmacology
15 papers in training set
Top 0.1%
5.3%
6
Frontiers in Cardiovascular Medicine
53 papers in training set
Top 0.6%
4.9%
7
Medicine
31 papers in training set
Top 0.3%
4.5%
50% of probability mass above
8
Journal of the American Heart Association
140 papers in training set
Top 2%
4.1%
9
Journal of Advanced Research
14 papers in training set
Top 0.1%
3.5%
10
Heliyon
152 papers in training set
Top 2%
2.8%
11
International Journal of Molecular Sciences
494 papers in training set
Top 6%
2.2%
12
Scientific Reports
3612 papers in training set
Top 52%
1.8%
13
Journal of Clinical Medicine
97 papers in training set
Top 2%
1.8%
14
BMC Cardiovascular Disorders
18 papers in training set
Top 0.6%
1.7%
15
International Journal of Cardiology
14 papers in training set
Top 0.6%
1.5%
16
Frontiers in Neurology
102 papers in training set
Top 2%
1.4%
17
The FASEB Journal
194 papers in training set
Top 3%
1.4%
18
Heart Rhythm
23 papers in training set
Top 0.5%
1.1%
19
Acta Biochimica et Biophysica Sinica
23 papers in training set
Top 0.4%
1.0%
20
PLOS Neglected Tropical Diseases
466 papers in training set
Top 5%
0.9%
21
Frontiers in Medicine
120 papers in training set
Top 4%
0.9%
22
Molecular Neurobiology
53 papers in training set
Top 1%
0.9%
23
Brain and Behavior
43 papers in training set
Top 2%
0.9%
24
RNA Biology
78 papers in training set
Top 1%
0.9%
25
Journal of Cellular and Molecular Medicine
20 papers in training set
Top 0.6%
0.9%
26
Journal of Cellular Physiology
25 papers in training set
Top 0.7%
0.9%
27
Microbial Pathogenesis
17 papers in training set
Top 0.4%
0.9%
28
Journal of Medical Virology
140 papers in training set
Top 3%
0.9%